| <p>Ajanta Pharma Limited disclosed that Aayush Agrawal, a promoter of the company, created a pledge on 11,25,000 equity shares and released a pledge on 10,25,000 equity shares, citing a new loan and top-up call as the reason for creation and loan closure for the release. The disclosures, made to the BSE and National Stock Exchange of India on November 6, 2026, also detailed pledge creation and release events involving other promoters and entities including Gabs Investments Pvt Ltd, Yogesh M Agrawal Trust, Rajesh Agrawal Trust, Ravi Agrawal Trust, Jio Credit Ltd, Bajaj Finance Ltd, Tata Capital Ltd, and CTL Trusteeship Ltd.</p> |